Advanced in Essential Thrombocythemia

Georg Holgersson

Uppsala, C, SE 
Advanced in Essential Thrombocythemia
Uppsala, C, SE 
OverviewLocationsClinical Research

Overview

Georg Holgersson practices in Uppsala, Sweden. Mr. Holgersson is rated as an Advanced expert by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Leukocytosis, Essential Thrombocythemia, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Essential Thrombocythemia.

Gender
Male

Locations

Uppsala, C, Sweden
Other Locations
Gaevle, X 80187, Sweden
Gavle, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Biological, Drug
Study Drugs: Niraparib, Pembrolizumab
Study Phase: Phase 3

26 Total Publications

Stable longitudinal symptom intensity in cancer patients during end-of-life palliative care at home: prospective cohort study.
Stable longitudinal symptom intensity in cancer patients during end-of-life palliative care at home: prospective cohort study.
Journal: BMJ supportive & palliative care
Published: March 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Holgersson's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile